These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34372693)

  • 1.
    Woolsey C; Borisevich V; Agans KN; Fenton KA; Cross RW; Geisbert TW
    mBio; 2021 Aug; 12(4):e0151721. PubMed ID: 34372693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.
    Woolsey C; Strampe J; Fenton KA; Agans KN; Martinez J; Borisevich V; Dobias NS; Deer DJ; Geisbert JB; Cross RW; Connor JH; Geisbert TW
    J Infect Dis; 2023 Nov; 228(Suppl 7):S712-S720. PubMed ID: 37290053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
    Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
    J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
    Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.
    Bornholdt ZA; Herbert AS; Mire CE; He S; Cross RW; Wec AZ; Abelson DM; Geisbert JB; James RM; Rahim MN; Zhu W; Borisevich V; Banadyga L; Gunn BM; Agans KN; Wirchnianski AS; Goodwin E; Tierney K; Shestowsky WS; Bohorov O; Bohorova N; Velasco J; Ailor E; Kim D; Pauly MH; Whaley KJ; Alter G; Walker LM; Chandran K; Zeitlin L; Qiu X; Geisbert TW; Dye JM
    Cell Host Microbe; 2019 Jan; 25(1):49-58.e5. PubMed ID: 30629918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System.
    Levine CB; Mire CE; Geisbert TW
    J Virol; 2021 Sep; 95(20):e0064321. PubMed ID: 34379503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.
    Gilchuk P; Guthals A; Bonissone SR; Shaw JB; Ilinykh PA; Huang K; Bombardi RG; Liang J; Grinyo A; Davidson E; Chen EC; Gunn BM; Alter G; Saphire EO; Doranz BJ; Bukreyev A; Zeitlin L; Castellana N; Crowe JE
    Front Immunol; 2021; 12():706757. PubMed ID: 34335620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.
    Wec AZ; Bornholdt ZA; He S; Herbert AS; Goodwin E; Wirchnianski AS; Gunn BM; Zhang Z; Zhu W; Liu G; Abelson DM; Moyer CL; Jangra RK; James RM; Bakken RR; Bohorova N; Bohorov O; Kim DH; Pauly MH; Velasco J; Bortz RH; Whaley KJ; Goldstein T; Anthony SJ; Alter G; Walker LM; Dye JM; Zeitlin L; Qiu X; Chandran K
    Cell Host Microbe; 2019 Jan; 25(1):39-48.e5. PubMed ID: 30629917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.
    Bramble MS; Hoff N; Gilchuk P; Mukadi P; Lu K; Doshi RH; Steffen I; Nicholson BP; Lipson A; Vashist N; Sinai C; Spencer D; Olinger G; Wemakoy EO; Illunga BK; Pettitt J; Logue J; Marchand J; Varughese J; Bennett RS; Jahrling P; Cavet G; Serafini T; Ollmann Saphire E; Vilain E; Muyembe-Tamfum JJ; Hensely LE; Simmons G; Crowe JE; Rimoin AW
    J Infect Dis; 2018 Nov; 218(12):1929-1936. PubMed ID: 30107445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
    Gilchuk P; Kuzmina N; Ilinykh PA; Huang K; Gunn BM; Bryan A; Davidson E; Doranz BJ; Turner HL; Fusco ML; Bramble MS; Hoff NA; Binshtein E; Kose N; Flyak AI; Flinko R; Orlandi C; Carnahan R; Parrish EH; Sevy AM; Bombardi RG; Singh PK; Mukadi P; Muyembe-Tamfum JJ; Ohi MD; Saphire EO; Lewis GK; Alter G; Ward AB; Rimoin AW; Bukreyev A; Crowe JE
    Immunity; 2018 Aug; 49(2):363-374.e10. PubMed ID: 30029854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.
    Singh K; Marasini B; Chen X; Ding L; Wang JJ; Xiao P; Villinger F; Spearman P
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.
    Jankeel A; Menicucci AR; Woolsey C; Fenton KA; Mendoza N; Versteeg K; Cross RW; Geisbert TW; Messaoudi I
    J Virol; 2020 May; 94(11):. PubMed ID: 32213610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates.
    Gilchuk P; Mire CE; Geisbert JB; Agans KN; Deer DJ; Cross RW; Slaughter JC; Flyak AI; Mani J; Pauly MH; Velasco J; Whaley KJ; Zeitlin L; Geisbert TW; Crowe JE
    J Infect Dis; 2018 Nov; 218(suppl_5):S565-S573. PubMed ID: 29982718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate Models.
    Mire CE; Geisbert TW
    Methods Mol Biol; 2017; 1628():293-307. PubMed ID: 28573630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.
    Flyak AI; Shen X; Murin CD; Turner HL; David JA; Fusco ML; Lampley R; Kose N; Ilinykh PA; Kuzmina N; Branchizio A; King H; Brown L; Bryan C; Davidson E; Doranz BJ; Slaughter JC; Sapparapu G; Klages C; Ksiazek TG; Saphire EO; Ward AB; Bukreyev A; Crowe JE
    Cell; 2016 Jan; 164(3):392-405. PubMed ID: 26806128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhuman Primate Models of Ebola Virus Disease.
    Bennett RS; Huzella LM; Jahrling PB; Bollinger L; Olinger GG; Hensley LE
    Curr Top Microbiol Immunol; 2017; 411():171-193. PubMed ID: 28643203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
    Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
    mBio; 2019 May; 10(3):. PubMed ID: 31138743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses.
    Pinski AN; Maroney KJ; Marzi A; Messaoudi I
    Emerg Microbes Infect; 2021 Dec; 10(1):1320-1330. PubMed ID: 34112056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.